The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 14, 2021

Filed:

Jan. 31, 2018
Applicant:

University of the Witwatersrand, Johannesburg, Johannesburg, ZA;

Inventors:

Yahya Essop Choonara, Johannesburg, ZA;

Pierre Pavan Demarco Kondiah, Johannesburg, ZA;

Pariksha Jolene Kondiah, Johannesburg, ZA;

Pradeep Kumar, Johannesburg, ZA;

Lisa Claire Du Toit, Johannesburg, ZA;

Thashree Marimuthu, Johannesburg, ZA;

Viness Pillay, Johannesburg, ZA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/52 (2006.01); A61L 27/16 (2006.01); A61L 27/18 (2006.01); A61L 27/26 (2006.01); B01J 31/12 (2006.01); C08L 67/02 (2006.01); C08L 67/04 (2006.01); C08J 3/075 (2006.01); A61L 27/50 (2006.01); C08G 63/08 (2006.01); C08L 67/06 (2006.01);
U.S. Cl.
CPC ...
A61L 27/52 (2013.01); A61L 27/16 (2013.01); A61L 27/18 (2013.01); A61L 27/26 (2013.01); B01J 31/12 (2013.01); C08L 67/02 (2013.01); C08L 67/04 (2013.01); A61L 2400/06 (2013.01); A61L 2430/02 (2013.01);
Abstract

This invention relates to thermoresponsive hydrogels. Particularly, the invention relates to a thermoresponsive hydrogel comprising copolymer polyethylene glycol (PEG)-polycaprolactone (PCL)-polyethylene glycol (PEG) and polypropylene fumerate (PPF). The thermoresponsive hydrogel may further comprise a poloxamer, particularly Pluronic F-127. The invention extends to a method of manufacturing thermoresponsive hydrogels, also extends to an ink for a three dimensional (3D) printer including the thermoresponsive hydrogels. The invention further extends to a thermoresponsive hydrogel for use in the treatment of a bone injury and/or a bone defect, and/or to a method of treating a bone injury and/or a bone defect. The thermoresponsive hydrogels may include dispersed therein an active pharmaceutical ingredient (API), preferably an API falling in the Biopharmaceutics Classification System (BCS) class II, further preferably a statin type drug, most preferably simvastatin.


Find Patent Forward Citations

Loading…